Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1990 February 1; 171(2): 533–544.
PMCID: PMC2187715

Lymphokine gene expression in vivo is inhibited by cyclosporin A


Murine T cells were stimulated in vivo by administering allogeneic cells or mitogens into the foot pads and then examining the draining popliteal lymph nodes. Allogeneic spleen cells induced the expression of IL2 and IFN-gamma mRNAs in a time- and dose-dependent manner. Induction of these transcripts also was detected after administration of Con A and anti-CD3 mAb. An increase in DNA-synthesizing cells was observed by 48 h, and these were shown to be T cells because of their sensitivity to anti-Thy-1 but not anti-B220 mAb and complement, and because of their localization to the T-dependent areas of the lymph node. The in vivo administration of cyclosporin A (CSA) reduced several of these T cell responses. The level of DNA synthesis and the frequency of cells synthesizing DNA were decreased by approximately 75%, while the induction of IL-2 responsiveness was not substantially diminished. IL-2 and IFN-gamma transcripts were inhibited at least 70-90%, as determined by Northern blot and in situ hybridization. Although the inhibition by CSA was not as complete in animals as observed previously in tissue culture, our findings indicate that in both systems, a major site of action of CSA is to inhibit T cell growth by inhibiting lymphokine production.

Full Text

The Full Text of this article is available as a PDF (905K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Granelli-Piperno A, Inaba K, Steinman RM. Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J Exp Med. 1984 Dec 1;160(6):1792–1802. [PMC free article] [PubMed]
  • Granelli-Piperno A, Andrus L, Steinman RM. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med. 1986 Apr 1;163(4):922–937. [PMC free article] [PubMed]
  • Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989 Jan 20;243(4889):355–361. [PubMed]
  • Zipfel PF, Irving SG, Kelly K, Siebenlist U. Complexity of the primary genetic response to mitogenic activation of human T cells. Mol Cell Biol. 1989 Mar;9(3):1041–1048. [PMC free article] [PubMed]
  • Elliott JF, Lin Y, Mizel SB, Bleackley RC, Harnish DG, Paetkau V. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science. 1984 Dec 21;226(4681):1439–1441. [PubMed]
  • Krönke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214–5218. [PubMed]
  • Reed JC, Abidi AH, Alpers JD, Hoover RG, Robb RJ, Nowell PC. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J Immunol. 1986 Jul 1;137(1):150–154. [PubMed]
  • Gauchat JF, Khandjian EW, Weil R. Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6430–6434. [PubMed]
  • Granelli-Piperno A, Keane M. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood. Transplant Proc. 1988 Apr;20(2 Suppl 2):136–142. [PubMed]
  • Kroczek RA, Black CD, Barbet J, Shevach EM. Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens. J Immunol. 1987 Dec 1;139(11):3597–3603. [PubMed]
  • Chisholm PM, Drayson MT, Cox JH, Ford WL. The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction. Eur J Immunol. 1985 Oct;15(10):1054–1059. [PubMed]
  • Granelli-Piperno A, Andrus L, Reich E. Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo. J Exp Med. 1984 Sep 1;160(3):738–750. [PMC free article] [PubMed]
  • Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374–1378. [PubMed]
  • Glisin V, Crkvenjakov R, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 1974 Jun 4;13(12):2633–2637. [PubMed]
  • Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. [PubMed]
  • Gray PW, Goeddel DV. Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5842–5846. [PubMed]
  • Shimuzu A, Kondo S, Takeda S, Yodoi J, Ishida N, Sabe H, Osawa H, Diamantstein T, Nikaido T, Honjo T. Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence. Nucleic Acids Res. 1985 Mar 11;13(5):1505–1516. [PMC free article] [PubMed]
  • Kashima N, Nishi-Takaoka C, Fujita T, Taki S, Yamada G, Hamuro J, Taniguchi T. Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature. 313(6001):402–404. [PubMed]
  • Granelli-Piperno A. In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A. J Exp Med. 1988 Nov 1;168(5):1649–1658. [PMC free article] [PubMed]
  • Andrus L, Lafferty KJ. Inhibition of T-cell activity by cyclosporin A. Scand J Immunol. 1981 May;15(5):449–458. [PubMed]
  • Huegin AW, Cerny A, Hengartner H, Zinkernagel RM. Suppression by cyclosporin A of murine T-cell-mediated immunity against viruses in vivo and in vitro. Cell Immunol. 1985 Feb;90(2):464–473. [PubMed]
  • Ryffel B, Feurer C, Heuberger B, Borel JF. Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment. Immunobiology. 1982 Dec;163(5):470–483. [PubMed]
  • Borel JF, Feurer C, Gubler HU, Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. [PubMed]
  • Miyawaki T, Yachie A, Ohzeki S, Nagaoki T, Taniguchi N. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells. J Immunol. 1983 Jun;130(6):2737–2742. [PubMed]
  • June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol. 1987 Dec;7(12):4472–4481. [PMC free article] [PubMed]
  • Lindstein T, June CH, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 1989 Apr 21;244(4902):339–343. [PubMed]
  • Laing TJ, Weiss A. Evidence for IL-2 independent proliferation in human T cells. J Immunol. 1988 Feb 15;140(4):1056–1062. [PubMed]
  • Granelli-Piperno A, Keane M, Steinman RM. Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody. J Immunol. 1989 Jun 15;142(12):4138–4143. [PubMed]
  • Tutschka PJ, Beschorner WE, Hess AD, Santos GW. Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood. 1983 Feb;61(2):318–325. [PubMed]
  • White DJ, Calne RY. The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev. 1982;65:115–131. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press